Biotechnology company
ZuriMED has raised €15M across 1 funding round from 3 investors, most recently a Series A round in Aug 2023. Based in Zurich, Switzerland; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-08-11 | Series A | €15M |
| Chindex Medical Limited,Private Investors,Yellowstone Holding AG |
| View deal → |
